New global contract for Byotrol

15-Jun-2007

Byotrol develops products for Fellowes, a provider of office accessories and business machines

Fellowes has access to a wide range of disinfectant technologies and chose Byotrol for its residual efficacy, ultra low toxicity profile and broadband action against a wide range of micro-organisms.

Fellowes is launching the Virashield range of products containing Byotrol across Europe with a global launch planned in the near future. The range, which includes wipes and hand protection foam, is designed to help combat the spread of infections in the workplace. Virashield offers residual efficacy of up to seven days with broad spectrum capability against a wide range of organisms including viruses such as influenza and avian flu and bacteria including E.coli.

Research has shown that a typical office desk harbours up to 400 times more bacteria than a typical toilet seat.

Sign up for your free email newsletter

The Virashield range has been extensively tested by both Byotrol and Fellowes and the tests have proven the product\'s efficacy for up to seven days following application.

Companies